By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bio-Rad Laboratories reported after the close of the market Thursday that its fourth-quarter revenues increased 8 percent, and 10 percent on a currency-neutral basis, led by a double-digit gain for its Clinical Diagnostics segment.

The Hercules, Calif.-based firm brought in total revenues of $533.7 million for the three-month period ended Dec. 31, compared to $495.1 million for Q4 2009. It easily beat analysts' consensus estimate of $514.5 million for the quarter.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.